Functional brain networks in Parkinson's disease.

Area of Science:

• Neuroscience
• Medical Imaging
• Systems Biology

Background:

• Movement disorders, particularly Parkinson's disease (PD), involve complex functional brain pathology.
• Network analysis of metabolic data offers a novel approach to understanding these disorders.
• Positron emission tomography (PET) provides crucial metabolic and blood flow data.

Purpose of the Study:

• To identify disease-related functional pathology patterns in movement disorders using PET and network analysis.
• To investigate the modulation of these networks by therapies for PD.
• To explore the role of brain networks in motor learning and their alterations in early PD.

Main Methods:

• Utilized [(18)F]-fluorodeoxyglucose (FDG)/PET to identify resting-state metabolic covariance patterns in PD.
• Employed [(15)O]-water (H(2) (15)O) PET to study brain activation during motor tasks.
• Applied network analysis to metabolic and blood flow data to assess brain function and learning.

Main Results:

• Identified a specific metabolic network in PD characterized by lentiform/thalamic hypermetabolism and cortical hypometabolism.
• Demonstrated that levodopa therapy and stereotaxic interventions modulate these abnormal PD networks.
• Showed that effective PD therapy enhances motor activation responses and can restore normal brain-behavior relationships in learning.

Conclusions:

• Functional brain imaging with network analysis provides mechanistic insights into basal ganglia disorders like PD.
• Therapeutic interventions for PD can normalize abnormal brain networks and improve motor and cognitive functions.
• This approach is valuable for understanding disease mechanisms and evaluating treatment efficacy.